Annie Ducher

534 total citations
9 papers, 285 citations indexed

About

Annie Ducher is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Annie Ducher has authored 9 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 4 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Annie Ducher's work include Clostridium difficile and Clostridium perfringens research (6 papers), Microscopic Colitis (3 papers) and Gut microbiota and health (3 papers). Annie Ducher is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (6 papers), Microscopic Colitis (3 papers) and Gut microbiota and health (3 papers). Annie Ducher collaborates with scholars based in France, Germany and Canada. Annie Ducher's co-authors include Jean de Gunzburg, Antoine Andremont, France Mentré, Violaine Augustin, Charles Burdet, Marina Varastet, Céline Féger, Xavier Duval, Élisabeth Chachaty and Nicolas Pons and has published in prestigious journals such as The Journal of Infectious Diseases, Critical Care Medicine and Clinical Pharmacology & Therapeutics.

In The Last Decade

Annie Ducher

9 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annie Ducher France 6 150 125 100 39 35 9 285
Loubna Alavoine France 6 130 0.9× 122 1.0× 66 0.7× 71 1.8× 24 0.7× 9 435
Oana Mariana Cristea Romania 8 114 0.8× 53 0.4× 57 0.6× 70 1.8× 23 0.7× 15 363
Dagmara I. Moscoso United States 6 93 0.6× 119 1.0× 45 0.5× 21 0.5× 28 0.8× 9 268
J Muszyński Poland 8 155 1.0× 161 1.3× 58 0.6× 48 1.2× 47 1.3× 35 351
Aikaterini Flevari Greece 8 171 1.1× 41 0.3× 125 1.3× 24 0.6× 16 0.5× 13 312
Yoichi Hiraki Japan 14 266 1.8× 52 0.4× 81 0.8× 111 2.8× 32 0.9× 41 536
Ankica Vujović Serbia 6 77 0.5× 244 2.0× 248 2.5× 17 0.4× 37 1.1× 12 490
Lindsay M. Busch United States 7 85 0.6× 147 1.2× 112 1.1× 29 0.7× 31 0.9× 12 333
Padade M. Vue United States 6 214 1.4× 55 0.4× 64 0.6× 26 0.7× 63 1.8× 7 513
Noe Reyes United States 6 227 1.5× 68 0.5× 99 1.0× 74 1.9× 18 0.5× 7 335

Countries citing papers authored by Annie Ducher

Since Specialization
Citations

This map shows the geographic impact of Annie Ducher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annie Ducher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annie Ducher more than expected).

Fields of papers citing papers by Annie Ducher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annie Ducher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annie Ducher. The network helps show where Annie Ducher may publish in the future.

Co-authorship network of co-authors of Annie Ducher

This figure shows the co-authorship network connecting the top 25 collaborators of Annie Ducher. A scholar is included among the top collaborators of Annie Ducher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annie Ducher. Annie Ducher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Vehreschild, Maria J. G. T., Annie Ducher, Thomas Louie, et al.. (2021). An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones. Journal of Antimicrobial Chemotherapy. 77(4). 1155–1165. 25 indexed citations
2.
Varastet, Marina, Céline Féger, Tanguy Corbel, et al.. (2021). A Colon‐Targeted Adsorbent (DAV132) Does Not Affect the Pharmacokinetics of Warfarin or Clonazepam in Healthy Subjects. Clinical Pharmacology in Drug Development. 10(8). 908–917. 2 indexed citations
3.
Ducher, Annie, Maria J. G. T. Vehreschild, Thomas Louie, et al.. (2020). LB-5. DAV132 Protects Intestinal Microbiota of Patients Treated with Quinolones, a European Phase II Randomized Controlled Trial (SHIELD). Open Forum Infectious Diseases. 7(Supplement_1). S845–S846. 2 indexed citations
4.
Guedj, Jérémie, Charles Burdet, Antoine Andremont, et al.. (2020). Modeling the Effect of DAV132, a Novel Colon‐Targeted Adsorbent, on Fecal Concentrations of Moxifloxacin and Gut Microbiota Diversity in Healthy Volunteers. Clinical Pharmacology & Therapeutics. 109(4). 1045–1054. 16 indexed citations
5.
Mayet, Aurélie, Hélène Delacour, France Mentré, et al.. (2018). High acquisition rate of extended-spectrum β-lactamase-producing Enterobacteriaceae among French military personnel on mission abroad, without evidence of inter-individual transmission. Clinical Microbiology and Infection. 25(5). 631.e1–631.e9. 10 indexed citations
6.
Gunzburg, Jean de, Amine Ghozlane, Annie Ducher, et al.. (2017). Protection of the Human Gut Microbiome From Antibiotics. The Journal of Infectious Diseases. 217(4). 628–636. 114 indexed citations
7.
Gunzburg, Jean de, Annie Ducher, Xavier Duval, et al.. (2015). DAV132, an Adsorbent-Based Product, Protects the Gut Microbiome and Prevents Clostridium difficile Infections During Moxifloxacin Treatments. Open Forum Infectious Diseases. 2(suppl_1). 4 indexed citations
8.
Gunzburg, Jean de, Annie Ducher, Christiane Modeß, et al.. (2014). Targeted adsorption of molecules in the colon with the novel adsorbent‐based Medicinal Product, DAV132: A proof of concept study in healthy subjects. The Journal of Clinical Pharmacology. 55(1). 10–16. 59 indexed citations
9.
Dellinger, R. Phillip, John Tomayko, Derek C. Angus, et al.. (2009). Efficacy and safety of a phospholipid emulsion (GR270773) in Gram-negative severe sepsis: Results of a phase II multicenter, randomized, placebo-controlled, dose-finding clinical trial. Critical Care Medicine. 37(11). 2929–2938. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Loubna Alavoine Breakdown of academic impact, for papers by Oana Mariana Cristea Breakdown of academic impact, for papers by Dagmara I. Moscoso Breakdown of academic impact, for papers by J Muszyński Breakdown of academic impact, for papers by Aikaterini Flevari Breakdown of academic impact, for papers by Yoichi Hiraki Breakdown of academic impact, for papers by Ankica Vujović Breakdown of academic impact, for papers by Lindsay M. Busch Breakdown of academic impact, for papers by Padade M. Vue Breakdown of academic impact, for papers by Noe Reyes
Rankless by CCL
2026